New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.

Over the last century, the U.S. armed forces resorted to asbestos-containing products as WWII demanded accessible materials ...

Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...

Lung cancer is the leading cause of cancer-related deaths, and the most common form is a non-small-cell type called adenocarcinoma.

Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...

Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...

AstraZeneca's cancer drug, datopotamab deruxtecan, failed to meet targets in a Phase 3 trial, clouding the possibility of approval from the U.S. Food and Drug Administration. Shares were down 1.2% at ...

Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...

New research highlights increased stroke, heart attack, and heart failure risks in cancer survivors, especially those treated ...

AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...

7 The American Lung Association has long supported the removal of menthol cigarettes from the marketplace. In April 2013, we submitted a formal petition to the FDA, requesting the prohibition of ...